Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX.
about
New viruses for cancer therapy: meeting clinical needsAdenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of CancerA novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous routeAdenoviral targeting using genetically incorporated camelid single variable domains.Synthetic virology: engineering viruses for gene deliveryChapter two--Adenovirus strategies for tissue-specific targeting.Use of microRNA Let-7 to control the replication specificity of oncolytic adenovirus in hepatocellular carcinoma cells.Development trends for generation of single-chain antibody fragments.Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer.Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents.Retargeting of viruses to generate oncolytic agents.Assessment of Specificity of an Adenovirus Targeted to HER3/4.Supraphysiological expression of survival motor neuron protein from an adenovirus vector does not adversely affect cell function.Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression.HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice.Development of an adenovirus vector vaccine platform for targeting dendritic cells.Designer Oncolytic Adenovirus: Coming of Age.
P2860
Q24567699-CA570A53-C0D2-420E-8992-E5970E1657CCQ27317286-DE635318-270E-4D88-8CAF-6C3C2811ABADQ28817910-16846BE3-3254-4CED-994B-3937A8901894Q34149036-ED57AC9E-59E6-446D-BFFC-2A0086843CBBQ34487264-A519C928-5256-483E-BC55-5D6B19FCDE30Q34643252-6C2816C7-8119-44EF-971B-F45E6E67682FQ35120104-B43AC1C7-C101-46D8-83D0-091D8204CE4DQ35216785-FA7824B8-4575-44E2-AEFF-38A518B8B9A1Q37393759-E96E8FFA-3E37-4104-9B99-67BE87A81A1AQ37628219-343911C2-A87C-46D3-A5AE-31CDE863FC44Q37982062-96B84F79-B7D0-4A67-9922-1A8F7193A975Q38645041-5641FC3F-085A-4E8E-B52F-2B1318E2F05FQ39125261-F306B917-575E-46C2-AAE8-F0ECC0D86AE8Q39595240-F5084549-95F1-472D-887D-8ADED791F881Q42288961-E65BE398-9BDC-47CE-9A4C-273D2BB141FEQ47248134-99C31BEA-5C9C-44B0-A0E0-DC637006D171Q55467684-5C549D7B-AC0B-47F9-A9FD-C1A1E91C9109
P2860
Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Retargeting of adenovirus vect ...... antibody to capsid protein IX.
@ast
Retargeting of adenovirus vect ...... antibody to capsid protein IX.
@en
Retargeting of adenovirus vect ...... antibody to capsid protein IX.
@nl
type
label
Retargeting of adenovirus vect ...... antibody to capsid protein IX.
@ast
Retargeting of adenovirus vect ...... antibody to capsid protein IX.
@en
Retargeting of adenovirus vect ...... antibody to capsid protein IX.
@nl
prefLabel
Retargeting of adenovirus vect ...... antibody to capsid protein IX.
@ast
Retargeting of adenovirus vect ...... antibody to capsid protein IX.
@en
Retargeting of adenovirus vect ...... antibody to capsid protein IX.
@nl
P2093
P2860
P356
P1433
P1476
Retargeting of adenovirus vect ...... antibody to capsid protein IX.
@en
P2093
Adam C Smith
Carin Christou
Ian A Lorimer
Karen L Powell
Kathy L Poulin
Milagros Risco Quiroz
Rashmi Kothary
Robert M Lanthier
Robin J Parks
Ryan W O'Meara
P2860
P304
10074-10086
P356
10.1128/JVI.02665-09
P407
P577
2010-07-14T00:00:00Z